Concentrix CEO disposes of 5,693 shares

Concentrix Corp President and CEO Christopher A. Caldwell, who also serves as a director, reported a disposition of company common stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Concentrix Corp President and CEO Christopher A. Caldwell, who also serves as a director, reported a disposition of company common stock. On 02/01/2026, he disposed of 5,693 shares at a price of $37.35 per share, in a transaction coded "F."

Following this transaction, Caldwell directly beneficially owned 356,382 shares of Concentrix common stock. The filing is made as a single‑person Form 4, reflecting his status as both an officer and director of the company.

Insider Trade Summary

Exercise Price or Tax Liability: 5,693 shares

Exercise Price or Tax Liability 1 txn

Insider Caldwell Christopher A

Role President and CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	5,693	$37.35	$213K

Holdings After Transaction: Common Stock — 356,382 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Concentrix (CNXC) report for its CEO?

Concentrix reported that President and CEO Christopher A. Caldwell disposed of 5,693 shares of common stock on 02/01/2026. The transaction was coded “F” and priced at $37.35 per share, according to the Form 4 filing.

At what price were Christopher Caldwell’s Concentrix (CNXC) shares transacted?

Christopher Caldwell’s reported Concentrix common stock transaction was priced at $37.35 per share. The Form 4 shows 5,693 shares disposed at this price, recorded under transaction code “F” on 02/01/2026.

How many Concentrix (CNXC) shares does the CEO own after the reported transaction?

After the reported transaction, President and CEO Christopher A. Caldwell beneficially owns 356,382 Concentrix common shares directly. This post‑transaction balance is listed in the Form 4 as the amount beneficially owned following the reported disposition.

What does transaction code “F” indicate in the Concentrix (CNXC) Form 4?

The Form 4 labels Christopher A. Caldwell’s 5,693‑share disposition with transaction code “F.” This code is part of the SEC’s standard transaction classifications, identifying the nature of the reported movement in his Concentrix common stock holdings.

What roles does Christopher A. Caldwell hold at Concentrix (CNXC)?

Christopher A. Caldwell is identified as both a director and an officer of Concentrix, serving as President and CEO. These roles are explicitly checked in the relationship section of the Form 4 reporting his common stock transaction.

Is Christopher Caldwell’s Concentrix (CNXC) stock ownership direct or indirect?

The Form 4 shows Christopher A. Caldwell’s Concentrix common stock ownership as direct. The ownership form column lists “D” for the 356,382 shares beneficially owned following the 5,693‑share disposition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/03/2026 - 04:08 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caldwell Christopher A

(Last)

(First)

(Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK

94560

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/01/2026		F		5,693	D	$37.35	356,382	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR